Search Within

Taha Merghoub

Formats
  1. Meeting Abstract (186)
  2. Journal Article (166)
  3. Book Section (3)
  4. Editorial (3)
  5. Review (3)
  6. Conference Paper (2)
  7. Guidelines (1)
Groups
  1. Department of Medicine (364)
  2. Melanoma and Immunotherapeutics Service (364)
  3. Solid Tumor Oncology Division (364)
  4. GSK Faculty (272)
  5. Sloan Kettering Institute Postdocs (207)
  6. Sloan Kettering Institute Faculty (95)

More Groups

People
  1. Jedd Wolchok (230)
  2. Sadna Budhu (75)
  3. Roberta Zappasodi (55)
  4. Cailian Liu (49)
  5. Alan Houghton (45)
  6. Daniel Hirschhorn Cymerman (42)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (7)
  4. 2022 (42)
  5. 2021 (25)
  6. 2020 (37)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (55)
  2. Cancer Research (44)
  3. Blood (29)
  4. Journal of Clinical Oncology (25)
  5. Journal of Investigative Dermatology (17)
  6. Journal of Immunology (12)

More Publications

Publishers
  1. American Association for Cancer Research (68)
  2. Biomed Central Ltd (55)
  3. American Society of Hematology (29)
  4. Nature Publishing Group (29)
  5. Cell Press (28)
  6. American Society of Clinical Oncology (26)

More Publishers

Results (364)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Myeloid-derived suppressor sells and the efficacy of CD8+ T-cell immunotherapy
    Journal Article

    Lesokhin, A. M.; Merghoub, T.; Wolchok, J. D.
    OncoImmunology (2013)

    Fulltext@MSK | Save
  • A role for the GITR pathway in anaphylaxis
    Meeting Abstract

    Murphy, J.; Merghoub, T.; Houghton, A.; Wolchok, J.
    Journal of Immunology (2013)

    Fulltext@MSK | Save
  • Effect of self antigen specific CD4+T cell precursor frequency on the anti-tumor immune response: Implications for adoptive T cell therapy
    Meeting Abstract

    Malandro, N.; Budhu, S.; Murphy, J.; Rizzuto, G.; Houghton, A.; Merghoub, T.; Wolchok, J.
    Journal of Immunology (2013)

    Fulltext@MSK | Save
  • OX40 engagement promotes potent tumoricidial CD4+T cells
    Meeting Abstract

    Hirschhorn-Cymerman, D.; Budhu, S.; Kitano, S.; Merghoub, T.; Wolchok, J.
    Journal of Immunology (2013)

    Fulltext@MSK | Save
  • TGF-β dependent suppression of effector T cell function within the tumor microenvironment
    Meeting Abstract

    Budhu, S.; Schaer, D.; Li, Y. B.; Houghton, A.; Silverstein, S.; Merghoub, T.; Wolchok, J.
    Journal of Immunology (2013)

    Fulltext@MSK | Save
  • Eradication of melanoma by intratumoral injection of attenuated vaccinia virus requires CD8+ T cells and combination of anti-CTLA-4 blockade and virotherapy enhances therapeutic efficacy in advanced melanoma
    Meeting Abstract

    Wu, X.; Dai, P.; Wang, W.; Avogadri, F.; Cao, H.; Parikh, T.; Jiang, X.; Halpern, A. C.; Houghton, A. N.; Shuman, S.; more...
    Journal of Investigative Dermatology (2013)

    Fulltext@MSK | Save
  • Modified vaccinia virus Ankara induces type I IFN induction in conventional dendritic cells through a STING-mediated cytosolic DNA sensing pathway that requires IRF3, IRF7 and IFNAR1
    Meeting Abstract

    Dai, P.; Wang, W.; Cao, H.; Avogadri, F.; Vance, R.; Merghoub, T.; Shuman, S.; Deng, L.
    Journal of Investigative Dermatology (2013)

    Fulltext@MSK | Save
  • The immunological impact of the RAF inhibitor BMS908662: Preclinical and early clinical experience in combination with CTLA-4 blockade
    Meeting Abstract

    Callahan, M.; Masters, G.; Katz, J.; Russell, V.; Roman, R. A.; Montefusco, M.; Vyas, S.; Yuan, J.; Merghoub, T.; Gupta, A. K.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype
    Journal Article

    Hirschhorn-Cymerman, D.; Budhu, S.; Kitano, S.; Liu, C.; Zhao, F.; Zhong, H.; Lesokhin, A. M.; Avogadri Connors, F.; Yuan, J.; Li, Y.; more...
    Journal of Experimental Medicine (2012)

    Fulltext@MSK | Save
  • Progression of RAS-mutant leukemia during RAF inhibitor treatment
    Journal Article

    Callahan, M. K.; Rampal, R.; Harding, J. J.; Klimek, V. M.; Chung, Y. R.; Merghoub, T.; Wolchok, J. D.; Solit, D. B.; Rosen, N.; Abdel-Wahab, O.; more...
    New England Journal of Medicine (2012)

    Fulltext@MSK | Save